Hypoglycemic effects of brassinosteroid in diet-induced obese mice

Debora Esposito, Pablo Kizelsztein, Slavko Komarnytsky, Ilya Raskin

Research output: Contribution to journalArticlepeer-review

12 Scopus citations


The prevalence of obesity is increasing globally, and obesity is a major risk factor for metabolic diseases such as type 2 diabetes. Previously, we reported that oral administration of homobrassinolide (HB) to healthy rats triggered a selective anabolic response that was associated with lower blood glucose. Therefore, the aim of this study was to evaluate the effects of HB administration on glucose metabolism, insulin sensitivity, body composition, and gluconeogenic gene expression profiles in liver of C57BL/6J high-fat diet-induced obese mice. Acute oral administration of 50-300 mg/kg HB to obese mice resulted in a dose-dependent decrease in fasting blood glucose within 3 h of treatment. Daily chronic administration of HB (50 mg/kg for 8 wk) ameliorated hyperglycemia and improved oral glucose tolerance associated with obesity without significantly affecting body weight or body composition. These changes were accompanied by lower expression of two key gluconeogenic enzymes, phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6-phosphatase (G-6-Pase), and increased phosphorylation of AMP-activated protein kinase in the liver and muscle tissue. In vitro, HB treatment (1-15 μM) inhibited cyclic AMP-stimulated but not dexamethasone-stimulated upregulation of PEPCK and G-6-Pase mRNA levels in H4IIE rat hepatoma cells. Among a series of brassinosteroid analogs related to HB, only homocastasterone decreased glucose production in cell culture significantly. These results indicate the antidiabetic effects of brassinosteroids and begin to elucidate their putative cellular targets both in vitro and in vivo.

Original languageEnglish (US)
Pages (from-to)E652-E658
JournalAmerican Journal of Physiology - Endocrinology and Metabolism
Issue number5
StatePublished - Sep 1 2012

All Science Journal Classification (ASJC) codes

  • Endocrinology, Diabetes and Metabolism
  • Physiology
  • Physiology (medical)


  • Diabetes
  • Glucose
  • Homobrassinolide
  • Insulin resistance
  • Phosphoenolpyruvate carboxykinase


Dive into the research topics of 'Hypoglycemic effects of brassinosteroid in diet-induced obese mice'. Together they form a unique fingerprint.

Cite this